Keywords: mylan, full-year, eps, hits, record, usa, laboratories
Mylan's full-year EPS hits record
Article | 24 May 2004
The USA's Mylan Laboratories achieved record earnings for the fiscal year ended March 31, 2004, of $334.6 million, or $1.21 per share, representing rises ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
